Application Nr Approved Date Route Status External Links
ANDA208518 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Doxylamine Succinate And Pyridoxine Hydrochloride Delayed-Release Tablets Are Indicated For The Treatment Of Nausea And Vomiting Of Pregnancy In Women Who Do Not Respond To Conservative Management. Limitations Of Use Doxylamine Succinate And Pyridoxine Hydrochloride Delayed-Release Tablet Has Not Been Studied In Women With Hyperemesis Gravidarum. Doxylamine Succinate And Pyridoxine Hydrochloride Delayed-Release Tablets Are A Fixed Dose Combination Drug Product Of Doxylamine Succinate, An Antihistamine, And Pyridoxine Hydrochloride, A Vitamin B6 Analog, Indicated For The Treatment Of Nausea And Vomiting Of Pregnancy In Women Who Do Not Respond To Conservative Management. (1)

All Formulated Excipients (0 Total)

None

Active Ingredients ( 2 Total)

Comments